HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

7- (4- (3- ethynylphenylamino)- 7- methoxyquinazolin- 6- yloxy)- N- hydroxyheptanamide

a histone deacetylase inhibitor; structure in first source
Also Known As:
CUDC 101; CUDC-101; CUDC101
Networked: 9 relevant articles (1 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Wang, Jing: 6 articles (04/2015 - 03/2010)
2. Atoyan, Ruzanna: 3 articles (04/2015 - 05/2010)
3. Lai, Cheng-Jung: 3 articles (06/2013 - 03/2010)
4. Cai, Xiong: 3 articles (06/2013 - 03/2010)
5. Ma, Anna W: 2 articles (04/2015 - 06/2013)
6. Voi, Maurizio: 2 articles (10/2014 - 06/2013)
7. Zhai, Hai-Xiao: 2 articles (05/2010 - 03/2010)
8. Yin, Ling: 2 articles (05/2010 - 03/2010)
9. Qian, Changgeng: 2 articles (05/2010 - 03/2010)
10. Bao, Rudi: 2 articles (05/2010 - 03/2010)

Related Diseases

1. Neoplasms (Cancer)
2. Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
3. Squamous Cell Carcinoma (Epidermoid Carcinoma)
4. Squamous Cell Neoplasms (Squamous Cell Cancer)
5. Stomach Neoplasms (Stomach Cancer)

Related Drugs and Biologics

1. Hydroxamic Acids (Hydroxamic Acid)
2. resminostat
3. PXD101
4. vorinostat (suberoylanilide hydroxamic acid)
5. Epidermal Growth Factor Receptor (EGF Receptor)
6. Histone Deacetylases (Histone Deacetylase)
7. Cadherins (E-Cadherin)
8. Phosphotransferases (Kinase)
9. anaplastic Thyroid cancer